Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal

seekingalpha.com/news/4519038-novo-nordisk-ends-metsera-fight-pfizer-inks-10b-dea

Quick Insights
- Pfizer's winning bid provides Metsera shareholders with a premium cash offer plus potential milestone payments, showing Pfizer's commitment to expanding in weight-loss drugs and responding to evolving regulatory challenges.
- Metsera's Board favored Pfizer's bid due to…

This story appeared on seekingalpha.com, 2025-11-08 20:39:46.646000.
The Entire Business World on a Single Page. Free to Use →